DR. MARK ANTHONY PETERS M.D.
NPI 1346245586
Ophthalmology in Portland, OR
Active since June 15, 2005
About Dr. Mark Anthony Peters M.d. NPPES
Official registry information on file with the National Plan and Provider Enumeration System.
DR. MARK ANTHONY PETERS M.D. (NPI 1346245586) is an individual ophthalmology provider in Portland, Oregon, licensed in Oregon (MD14091) and active in the NPI registry since June 2005.
NPPES Registry Identity
NPI1346245586
Entity TypeIndividualMale
Primary Taxonomy207W00000X
Provider Legal NameDR. MARK ANTHONY PETERSCredential: M.D.
Location Address2525 NW LOVEJOY ST, STE 100Portland, OR 97210-2861
Mailing Address2525 Nw Lovejoy St, Ste 100Portland, OR 97210-2861
Phone(503) 274-2121
Sole ProprietorNo
Enumeration DateJune 15, 2005
Last NPPES UpdateJuly 13, 2007
✔ NPI 1346245586 is a valid, active identifier and passes the ISO check-digit test.
Specialties & Licenses
★ Primary SpecialtyOphthalmologyAllopathic & Osteopathic Physicians
Taxonomy Code207W00000X
Licenses✔ Licensed in OR · MD14091✔ Licensed in WA · MD00024996
Definition
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
2525 NW LOVEJOY ST, Portland, OR 97210
Other Identifiers 1
Medicare UPINC93507OR
Medicare Quality Performance CMS QPP · MIPS
Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.
Reported Quality Measures
Age-Related Macular Degeneration (AMD): Counseling on Antioxidant Supplement
Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) or their caregiver(s) who were counseled within 12 months on the benefits and/or risks of the Age-Related Eye Disease Study (AREDS) formulation for…
83%550 patients4/55-star benchmark: 100%
Age-Related Macular Degeneration (AMD): Dilated Macular Examination
Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) who had a dilated macular examination performed which included documentation of the presence or absence of macular thickening or geographic atrophy or…
100%550 patients5/55-star benchmark: 100%
Diabetes: Eye Exam
Percentage of patients 18-75 years of age with diabetes who had a retinal or dilated eye exam by an eye care professional during the measurement period or a negative retinal exam (no evidence of retinopathy) in the 12 months prior to the measurement period
100%263 patients5/55-star benchmark: 100%
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented communication to the physician who manages the ongoing care of the patient with diabetes mellitus…
91%277 patients4/55-star benchmark: 100%
Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed which included documentation of the level of severity of retinopathy and the presence or absence of macular edema during…
99%280 patients4/55-star benchmark: 100%
Documentation of Current Medications in the Medical Record
Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
99%3,396 patients4/55-star benchmark: 100%
e-Prescribing
At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology.
87%271 patients4/55-star benchmark: 100%
Health Information Exchange
The MIPS eligible clinician that transitions or refers their patient to another setting of care or health care clinician (1) uses CEHRT to create a summary of care record; and (2) electronically transmits such summary to a receiving health care clinician for…
78%60 patients4/55-star benchmark: 98%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
99%146 patients4/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
89%916 patients4/55-star benchmark: 100%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
3%407 patients1/55-star benchmark: 90%
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the previous twelve months AND with a BMI outside of normal parameters, a follow-up plan is documented during the encounter or during the previous…
2%667 patients1/55-star benchmark: 97%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
Patients screenedForUse: 87% · 879 patients
Patients tobacco: 83% · 879 patients
45%64 patients2/55-star benchmark: 98%
Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) who have an optic nerve head evaluation during one or more office visits within 12 months
100%243 patients5/55-star benchmark: 100%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
98%916 patients4/55-star benchmark: 100%
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
16%916 patients1/55-star benchmark: 79%
Use of High-Risk Medications in the Elderly
Percentage of patients 65 years of age and older who were ordered high-risk medications. Two rates are submitted. 1) Percentage of patients who were ordered at least one high-risk medication.
Lower rates are better for this measure.
Patients 2+: 0% · 905 patients
0%905 patients5/55-star benchmark: 100%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.
Other Providers at the Same Location NPPES 20
Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.
Counselor (Professional)
2525 NW LOVEJOY ST, SUITE 407
PORTLAND, OR 97210
PORTLAND, OR 97210
Frequently Asked Questions NPPES & CMS
Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.
What is Mark Peters's NPI number?
The NPI number for Mark Peters is 1346245586. It was assigned to this individual provider in the NPPES registry on June 15, 2005.
Where is Mark Peters located?
Mark Peters practices at 2525 NW Lovejoy St Ste 100, Portland, OR 97210. The listed phone number is (503) 274-2121.
What is Mark Peters's specialty?
The primary specialty registered for this NPI is Ophthalmology with taxonomy code 207W00000X.
When was this NPI record last updated?
The NPPES record for Mark Peters was last updated on July 13, 2007. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 19 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.
# Dr. Mark Anthony Peters, M.D. · NPI 1346245586
Ophthalmology physician in Portland, Oregon. Individual provider, active in the CMS NPPES registry since June 15, 2005.
## Identity
- **NPI:** 1346245586 (Entity type: Individual)
- **Enumerated:** June 15, 2005
- **Primary specialty:** Ophthalmology · taxonomy 207W00000X
- **State license:** MD14091 (Oregon)
- **Sole proprietor:** No
## Practice location
- **Address:** 2525 NW LOVEJOY ST, STE 100, Portland, OR 97210-2861
- **Phone:** (503) 274-2121
## Record status
- **NPPES last updated:** July 13, 2007
- **Other identifiers:** Medicare UPIN C93507 (OR)
---
Source: [NPI Profile](https://npiprofile.com/npi/1346245586) · Data from the CMS NPPES public registry.